Filing Details

Accession Number:
0001181431-11-004551
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-20 18:12:49
Reporting Period:
2011-01-18
Filing Date:
2011-01-20
Accepted Time:
2011-01-20 18:12:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1011835 Medivation Inc. MDVN Pharmaceutical Preparations (2834) 133863260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1327111 Lynn Seely C/O Medivation, Inc.
201 Spear Street, 3Rd Floor
San Francisco CA 94105
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-18 25,000 $3.60 41,666 No 4 M Direct
Common Stock Disposition 2011-01-18 25,000 $15.59 16,666 No 4 S Direct
Common Stock Acquisiton 2011-01-19 25,000 $3.60 41,666 No 4 M Direct
Common Stock Disposition 2011-01-19 25,000 $14.45 16,666 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-01-18 25,000 $0.00 25,000 $3.60
Common Stock Stock Option (Right to Buy) Disposition 2011-01-19 25,000 $0.00 25,000 $3.60
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
191,000 2015-03-14 No 4 M Direct
166,000 2015-03-14 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 Plan.
  2. The shares were sold at prices between $15.19 and $16.01. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares were sold at prices between $14.29 and $14.57. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The option is immediately exercisable, in whole or in part, and the shares subject to the option vest according to the following schedule: 25% of the shares subject to the option vested on March 14, 2006, and 1/48th of the shares subject to the option vested and continue to vest on the first day of each full month thereafter so that all of the shares subject to the option shall be fully vested on March 1, 2009.